Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
UXC | Ann: Removal from the Official List at Close of Trading | 29/02/16 | 0 | 1.4K | |||
|
|||||||
UXC | Ann: Implementation of Scheme of Arrangement | 29/02/16 | 0 | 1.1K | |||
|
|||||||
UXC | Ann: Ceasing to be a substantial holder | 17/02/16 | 0 | 753 | |||
|
|||||||
UXC | Ann: Becoming a substantial holder | 12/02/16 | 0 | 774 | |||
|
|||||||
UXC | Ann: Appendix 3B - Performance Rights | 12/02/16 | 0 | 1.2K | |||
|
|||||||
UXC | Ann: Suspension from Official Quotation - Close of Trading Today | 12/02/16 | 0 | 889 | |||
|
|||||||
UXC | News: UXC UXC says court approves scheme of arrangement | 11/02/16 | 0 | 974 | |||
|
|||||||
UXC | Ann: Court Approves Scheme of Arrangement | 11/02/16 | 0 | 650 | |||
|
See All Discussions